Taking everything into account, NVCT scores 2 out of 10 in our fundamental rating. NVCT was compared to 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for NVCT as it has an excellent financial health rating, but there are worries on the profitability. NVCT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

NVCT had negative earnings in the past year.
In the past year NVCT has reported a negative cash flow from operations.
In the past 5 years NVCT always reported negative net income.
In the past 5 years NVCT always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -78.14%, NVCT is doing worse than 65.90% of the companies in the same industry.
NVCT has a Return On Equity of -115.81%. This is comparable to the rest of the industry: NVCT outperforms 41.52% of its industry peers.

		Industry Rank	Sector Rank
ROA	-78.14%
ROE	-115.81%
ROIC	N/A

ROA(3y)-103.89%

ROA(5y)N/A

ROE(3y)-170.77%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NVCT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, NVCT has more shares outstanding
There is no outstanding debt for NVCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 6.34 indicates that NVCT is not in any danger for bankruptcy at the moment.
NVCT has a Altman-Z score of 6.34. This is in the better half of the industry: NVCT outperforms 75.43% of its industry peers.
There is no outstanding debt for NVCT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	6.34

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

NVCT has a Current Ratio of 3.07. This indicates that NVCT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NVCT (3.07) is worse than 63.24% of its industry peers.
A Quick Ratio of 3.07 indicates that NVCT has no problem at all paying its short term obligations.
NVCT's Quick ratio of 3.07 is on the low side compared to the rest of the industry. NVCT is outperformed by 61.14% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.07
Quick Ratio	3.07

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NVCT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.62%.

EPS 1Y (TTM)-8.62%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-37.5%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

NVCT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.28% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-19.46%

EPS Next 2Y2.42%

EPS Next 3Y-0.28%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVCT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NVCT. No positive earnings are expected for the next year.